Top compounds associated with response to ERAL1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.08
mRNA AT7867 CTRPv2 pan-cancer AAC 0.062 0.08
mRNA XL-184 GDSC1000 pan-cancer AAC -0.059 0.08
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.057 0.08
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.085 0.09
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.063 0.09
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.059 0.09
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.056 0.09
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC -0.063 0.09
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.09
Download CSV